Copy
Delivering your source of carbohydrates. - April 2020

Top stories this month:

Glycovax Pharma develops a vaccine against COVID-19

Co-founded by GlycoNet Investigator, the biopharma company is developing a semi-synthetic vaccine in the preclinical phase.

 

GlycoNet-affiliated startup searches for antiviral compounds to treat COVID-19

48Hour Discovery aims to develop clinically useful compounds by December 2020.

Antiviral used to treat cat coronavirus could hold key to COVID-19

Network Investigator teams up with researchers to look for action against deadly human virus.

U of Calgary scientists receive grant to discover medications for COVID-19

GlycoNet Investigators are looking for lead antiviral compounds for more effective COVID-19 treatments.

 

In case you missed it:

What immunity to COVID-19 really means

Dr. Dawn Bowdish, Network Investigator, was interviewed in the latest Scientific American.

Lessons learned from SARS-CoV-2 for superbugs

Network Investigator Dr. Burrows gives a commentary on Global News.
GlycoNet Webinar rewind: "3D models of glycosylated SARS-CoV-2 protein" by Dr. Robert Woods
Don't miss out on our future workshops and seminars. Check out the GlycoNet webinar series here >>

Call for Abstracts: Canadian Glycomics Virtual Poster Session

We have worked to transition the in-person poster session from the now-canceled Symposium to a virtual event where researchers can interact and network through live presentations. Learn more >>

Call for Proposals: Translational Grant and Strategic Initiative Grant

GlycoNet is providing support for collaborations between academic researchers, public and not-for-profit sectors, and industry to address unmet healthcare needs. We encourage researchers who have innovative glycomics solutions for COVID-19 to apply ASAP. Next application deadline is June 15, 2020. Learn more >>

Coronaviruses, SARS-CoV-2 & Glycan Meeting

Hosted by NIH on Friday, May 1, 11 am - 3 pm MDT. Register here >>
GlycoNet Webinar Series
Stay engaged with the latest research and technologies. Learn more >>

Post Doc, not PhD 2.0

What's good about pursuing a post-doc and what are some cautionary tales?

Have you met Peter Rahfeld?

Dr. Rahfeld has a passion for CAZymes. Find out why.

Selected publications:

Remember to cite the GlycoNet doi: 10.13039/501100009056
Copyright © 2019 Canadian Glycomics Network (GlycoNet), All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Canadian Glycomics Network · E5-33 Chemistry Centre, University of Alberta · Edmonton, AB T6G 2G2 · Canada

Email Marketing Powered by Mailchimp